Beneficient (BENFW) — SEC Filings

Overview

Beneficient (BENFW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a S-1 filed on Dec 23, 2025: Beneficient (BENFW) filed an S-1 on December 23, 2025, to register the resale of up to 71,017,840 shares of Class A common stock by various selling holders. This includes 64,371,217 shares potentially issued to Yorkville under a Standby Equity Purchase Agreement (SEPA) for up to $250 million, of whi

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 11 bearish, 39 neutral. The dominant filing sentiment for Beneficient is neutral.

Filing Type Overview

Beneficient (BENFW) has filed 2 S-1, 27 8-K, 4 10-Q, 2 DEF 14A, 1 10-K, 10 DEFA14A, 1 SC 13G/A, 2 S-1/A, 1 SC 13D/A with the SEC between Oct 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (50)

• Beneficient Registers 71M Shares for Resale Amidst Yorkville Funding — S-1 · Dec 23, 2025 Risk: high
  Beneficient (BENFW) filed an S-1 on December 23, 2025, to register the resale of up to 71,017,840 shares of Class A common stock by various selling holders. Thi
• 8-K Filing — 8-K · Dec 17, 2025
• Beneficient Files 8-K on Security Holder Rights — 8-K · Dec 11, 2025 Risk: medium
  On December 10, 2025, Beneficient filed an 8-K report detailing material modifications to the rights of security holders and amendments to its articles of incor
• Beneficient Files 8-K with Financials and Exhibits — 8-K · Dec 10, 2025 Risk: low
  On December 10, 2025, Beneficient filed an 8-K report detailing its financial statements and exhibits. The company, incorporated in Nevada with the ticker symbo
• 8-K Filing — 8-K · Dec 2, 2025
• Beneficient's Future in Doubt Amidst Soaring Losses, Arbitration Hit — 10-Q · Nov 14, 2025 Risk: high
  Beneficient reported a significant net loss of $110.555 million for the six months ended September 30, 2025, a stark contrast to a net income of $54.057 million
• Beneficient Seeks Reverse Stock Split to Avoid Nasdaq Delisting — DEF 14A · Nov 6, 2025 Risk: high
  Beneficient (BENFW) is seeking stockholder approval for a reverse stock split at a ratio between 1-for-5 and 1-for-100, as determined by its Board of Directors.
• Beneficient Files 8-K for Nov 5, 2025 — 8-K · Nov 5, 2025 Risk: low
  On November 5, 2025, Beneficient filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. Beneficient, fo
• Beneficient Files 8-K with Financials and Disclosures — 8-K · Oct 30, 2025 Risk: low
  On October 29, 2025, Beneficient filed an 8-K report detailing several events. The filing includes financial statements and exhibits, and also serves as a Regul
• Beneficient Files 8-K: Equity Sales & Financials — 8-K · Oct 21, 2025 Risk: medium
  On October 15, 2025, Beneficient reported unregistered sales of equity securities and a Regulation FD disclosure. The filing also included financial statements
• Beneficient Plunges to $92.6M Loss Amid Arbitration Hit, Nasdaq Woes — 10-Q · Oct 20, 2025 Risk: high
  Beneficient reported a significant net loss of $92.6 million for the three months ended June 30, 2025, a stark contrast to the net income of $44.3 million in th
• Beneficient Faces Delisting Concerns — 8-K · Oct 9, 2025 Risk: high
  Beneficient filed an 8-K on October 9, 2025, reporting a notice of delisting or failure to satisfy continued listing rules as of October 3, 2025. The company, i
• Beneficient Grapples with Nasdaq Delisting Threat, Loan Defaults, and Going Concern Doubts — 10-K · Sep 29, 2025 Risk: high
  Beneficient (BENFW) reported for the fiscal year ended March 31, 2025, highlighting significant operational and financial challenges. The company, a technology-
• Beneficient Files 8-K: Regulation FD, Other Events, Financials — 8-K · Sep 16, 2025 Risk: low
  On September 9, 2025, Beneficient filed an 8-K report detailing events including a Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits
• Beneficient Faces Delisting Concerns in 8-K Filing — 8-K · Aug 22, 2025 Risk: high
  Beneficient filed an 8-K on August 22, 2025, reporting events as of August 18, 2025. The filing indicates a notice of delisting or failure to satisfy a continue
• Beneficient 8-K: Financial Obligation Trigger Event — 8-K · Aug 5, 2025 Risk: medium
  On July 30, 2025, Beneficient (BENF) filed an 8-K report detailing a triggering event that accelerates or increases a direct financial obligation. The filing in
• Beneficient Files 8-K on Officer/Director Changes — 8-K · Jul 21, 2025 Risk: medium
  Beneficient filed an 8-K on July 21, 2025, reporting on July 20, 2025, regarding the departure of directors or certain officers, election of directors, appointm
• Beneficient Files 8-K on Delisting Concerns — 8-K · Jul 18, 2025 Risk: high
  Beneficient filed an 8-K on July 18, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, along with Regulation FD
• Beneficient DEFA14A Filing Details Corporate Information — DEFA14A · Jun 25, 2025 Risk: low
  Beneficient filed a DEFA14A on June 25, 2025, reporting on events up to June 17, 2025. The filing details the company's corporate structure and operations, incl
• Beneficient Files 8-K Report — 8-K · Jun 17, 2025 Risk: low
  On June 17, 2025, Beneficient filed an 8-K report detailing other events and financial statements. The company, formerly known as Beneficient Co Group, L.P., is
• Beneficient Terminates Material Definitive Agreement — 8-K · Jun 10, 2025 Risk: medium
  Beneficient announced on June 3, 2025, the termination of a material definitive agreement. The company, incorporated in Nevada, filed this 8-K report on June 10
• Beneficient Reports on Shareholder Votes — 8-K · Jun 4, 2025 Risk: low
  Beneficient filed an 8-K on June 4, 2025, reporting on matters submitted to a vote of security holders as of May 29, 2025. The filing details the company's comm
• Beneficient Adjourns Annual Meeting to May 29 — DEFA14A · May 28, 2025 Risk: low
  Beneficient (NASDAQ: BENF) announced on May 28, 2025, that it has adjourned its Annual Meeting of Stockholders. The meeting will now take place at 2 p.m. CDT on
• Beneficient Files Proxy Statement — DEFA14A · May 16, 2025 Risk: low
  Beneficient (BENF) filed a DEFA14A on May 16, 2025, indicating a proxy statement. The filing was made on May 15, 2025, and concerns the company's operations. Be
• Beneficient Adjourns Annual Stockholder Meeting — DEFA14A · Apr 30, 2025 Risk: medium
  Beneficient (NASDAQ: BENF) announced on April 30, 2025, that it has adjourned its Annual Meeting of Stockholders. The company, formerly known as Beneficient Co
• Beneficient Files DEFA14A Proxy Statement — DEFA14A · Apr 25, 2025 Risk: low
  Beneficient, formerly Beneficient Co Group, L.P., filed a DEFA14A on April 25, 2025, reporting events as of April 21, 2025. The company, incorporated in Nevada
• Beneficient Urges Stockholders to Vote for Annual Meeting — DEFA14A · Apr 23, 2025 Risk: low
  Beneficient is reminding stockholders to vote on proxy proposals before their Annual Meeting scheduled for April 30, 2025. The company, headquartered in Dallas,
• Beneficient Adjourns Annual Meeting of Stockholders — DEFA14A · Apr 16, 2025 Risk: medium
  Beneficient (NASDAQ: BENF) announced on April 16, 2025, that it has adjourned its Annual Meeting of Stockholders. The company did not provide specific reasons f
• Beneficient Files 8-K on Equity Sales & Bylaw Changes — 8-K · Apr 7, 2025 Risk: medium
  On April 4, 2025, Beneficient filed an 8-K report detailing unregistered sales of equity securities and material modifications to security holder rights. The fi
• Beneficient Adjourns Annual Meeting of Stockholders — DEFA14A · Mar 31, 2025 Risk: medium
  Beneficient (NASDAQ: BENF) announced on March 31, 2025, that it has adjourned its Annual Meeting of Stockholders. The company has not provided a new date for th
• Beneficient Files 2025 Proxy Statement — DEF 14A · Mar 21, 2025 Risk: low
  Beneficient, a finance services company, filed its DEF 14A proxy statement on March 21, 2025, for its annual meeting of stockholders. The filing details informa
• Beneficient Files 8-K: Material Agreement and Disclosures — 8-K · Mar 10, 2025 Risk: medium
  On March 6, 2025, Beneficient entered into a material definitive agreement. The company also provided a Regulation FD disclosure and reported other events, incl
• Beneficient Files 8-K on Shareholder Nominations — 8-K · Feb 28, 2025 Risk: low
  Beneficient filed an 8-K on February 28, 2025, reporting on shareholder nominations and other events as of February 27, 2025. The filing details information abo
• Beneficient Files 10-Q for Q3 FY2025 — 10-Q · Feb 14, 2025 Risk: medium
  Beneficient filed its 10-Q for the period ending December 31, 2024. The company, incorporated in Nevada and headquartered in Dallas, TX, operates in the finance
• Beneficient Files DEFA14A Proxy Statement — DEFA14A · Feb 13, 2025 Risk: low
  Beneficient filed a DEFA14A on February 13, 2025, detailing its corporate actions. The filing, which is a definitive proxy statement, provides information to sh
• 8-K Filing — 8-K · Jan 22, 2025
• Beneficient Faces Delisting Concerns — 8-K · Jan 17, 2025 Risk: high
  Beneficient (BENF) filed an 8-K on January 17, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The earliest ev
• Beneficient Files Definitive Proxy Statement — DEFA14A · Jan 6, 2025 Risk: low
  Beneficient filed a DEFA14A on January 6, 2025, reporting an event date of December 30, 2024. The filing pertains to Beneficient, a Nevada-based company in the
• Beneficient Files 8-K for Material Definitive Agreement — 8-K · Dec 23, 2024 Risk: medium
  On December 22, 2024, Beneficient entered into a material definitive agreement. The filing does not provide specific details about the agreement or any associat
• Beneficient Files 8-K for Material Agreement and Equity Sales — 8-K · Dec 5, 2024 Risk: medium
  On December 4, 2024, Beneficient entered into a material definitive agreement related to the issuance of shares of its Class Common Stock and warrants. The comp
• Beneficient Files 8-K with Financials and Exhibits — 8-K · Dec 4, 2024 Risk: low
  On December 4, 2024, Beneficient filed an 8-K report. The filing primarily concerns financial statements and exhibits, and includes a Regulation FD Disclosure.
• Beneficient Faces Delisting Concerns — 8-K · Nov 26, 2024 Risk: high
  Beneficient (BENF) filed an 8-K on November 26, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The company is also providi
• Beneficient Faces Delisting Concerns, Elects New Directors — 8-K · Nov 22, 2024 Risk: high
  Beneficient filed an 8-K on November 21, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The company also disclosed the dep
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Beneficient Files Q3 2024 10-Q — 10-Q · Nov 14, 2024 Risk: low
  Beneficient filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Beneficient Co Group, L.P., is incorporated in Nevada and op
• Beneficient Files S-1/A Amendment — S-1/A · Nov 8, 2024 Risk: medium
  Beneficient filed an S-1/A amendment on November 8, 2024, detailing its financial position. The company, incorporated in Nevada with its principal office in Dal
• Beneficient Files 8-K: Regulation FD & Financials — 8-K · Oct 30, 2024 Risk: low
  On October 30, 2024, Beneficient filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The filing includes information
• Beneficient Files S-1/A Update — S-1/A · Oct 24, 2024 Risk: medium
  Beneficient filed an S-1/A on October 24, 2024, detailing its financial status. The company, incorporated in Nevada with its principal office in Dallas, TX, ope
• Beneficient Files S-1 Registration Statement — S-1 · Oct 22, 2024 Risk: medium
  Beneficient, formerly Beneficient Co Group, L.P., filed an S-1 form on October 22, 2024. The company, incorporated in Nevada with its principal office in Dallas
• GWG Wind Down Trust Amends Beneficient 13D Filing — SC 13D/A · Oct 8, 2024 Risk: medium
  On October 8, 2024, the GWG Wind Down Trust, represented by Elizabeth C. Freeman, filed an amendment to its Schedule 13D regarding Beneficient. This filing indi

Risk Profile

Risk Assessment: Of BENFW's 46 recent filings, 11 were flagged as high-risk, 17 as medium-risk, and 18 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Beneficient's most recent 10-Q filing (Nov 14, 2025):

• Revenue: -$15,386,000
• Net Income: -$110,555,000
• EPS: -$0.37
• Debt-to-Equity: N/A
• Cash Position: $4,902,000
• Operating Margin: N/A
• Total Assets: $316,233,000
• Total Debt: $103,960,000

Key Executives

• Brad K. Heppner
• James G. Silk
• David B. Rost
• Elizabeth C. Freeman

Industry Context

Beneficient operates in a sector that often relies on complex financial instruments and strategic partnerships for growth. The company's reliance on equity financing, particularly through agreements like the SEPA, is common in industries requiring substantial capital investment. The competitive landscape likely involves other companies seeking similar funding mechanisms and facing similar market pressures.

Top Tags

proxy-statement (11) · corporate-governance (7) · financials (7) · sec-filing (7) · financial-statements (6) · delisting (6) · regulation-fd (5) · Reverse Stock Split (4) · 8-K (4) · disclosure (4)

Key Numbers

• Shares of Class A common stock: 71,017,840 — Total shares registered for resale by Selling Holders
• Maximum amount under SEPA: $250 million — Total potential funding from Yorkville via Standby Equity Purchase Agreement
• Amount utilized under SEPA: $9.3 million — Aggregate price for 613,972 shares sold to Yorkville under SEPA
• Remaining available under SEPA: $240.7 million — Unused portion of the Standby Equity Purchase Agreement with Yorkville
• SEPA Shares: 64,371,217 — Shares of Class A common stock that may be issued and sold to Yorkville under the SEPA
• Warrant Shares: 165,674 — Shares of Class A common stock issuable upon exercise of warrants held by Yorkville
• Warrant exercise price: $21.04 — Exercise price for warrants held by Yorkville
• Authorized Class A common stock: 625,000,000 — Number of authorized shares after the December 15, 2025 reverse stock split
• Class A common stock closing price: $6.85 — Last reported sales price on December 19, 2025
• Public Warrants closing price: $0.0137 — Last reported sales price on December 19, 2025
• Report Date: 20251210 — The date of the earliest event reported in the 8-K filing.
• Net Loss: $110.555M — For the six months ended September 30, 2025, a significant deterioration from a $54.057M net income in the prior year.
• Total Revenues (Loss): $15.386M — For the six months ended September 30, 2025, a sharp decline from $18.607M in the prior year, indicating core business struggles.
• Arbitration Accrual: $62.831M — A major operating expense for the six months ended September 30, 2025, significantly impacting profitability.
• Total Liabilities: $368.534M — As of September 30, 2025, an increase from $299.274M as of March 31, 2025, highlighting growing financial obligations.

Related Companies

BENF

Frequently Asked Questions